SCHEMBL24809304

SCHEMBL24809304

CC1(C)CCC(C)(C)c2cc(-c3ccccc3Cl)c(Br)cc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 7/20 0.38
RARB P10826 5/20 0.38
RARG P13631 4/20 0.38
HSD11B1 P28845 2/20 0.36
PLA2G7 Q13093 1/20 0.36
RARA P10276 2/20 0.34
PGR P06401 3/20 0.33
CYP2A6 P11509 1/20 0.33
KMT2A Q03164 3/20 0.33
POLB P06746 1/20 0.33
DPP4 P27487 1/20 0.33
GABRA1 P14867 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
GABRA2 P47869 1/20 0.32
GABRB2 P47870 1/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24809860 0.90 HSD11B1 (0.36) HSD11B1PLA2G7PGRCYP2A6KMT2A
SCHEMBL21662224 0.86 HSD11B1 (0.38) RXRARARBRARGHSD11B1RARA
SCHEMBL29608697 0.82 RXRA (0.45) RXRARARBRARGRARA
SCHEMBL25129965 0.82 RXRA (0.45) RXRARARBRARGRARA
SCHEMBL21662016 0.79 HSD11B1 (0.33) RXRARARBRARGHSD11B1PGR
SCHEMBL27328115 0.78 RARB (0.47) RXRARARBRARGRARAKMT2A
SCHEMBL18015371 0.77 MAPK1 (0.41) RXRARARBRARGRARAKMT2A
SCHEMBL19794368 0.77 MAPK1 (0.41) RXRARARBRARGRARAKMT2A
SCHEMBL24794240 0.75 RARG (0.58) RXRARARBRARGRARAPGR
SCHEMBL24809301 0.75 RXRA (0.40) RXRARARBRARGRARAPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11807616-B2 Organic compound, and electronic element and electronic device using same SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-11-07 US disclosed
US-11807616-B2 Organic compound, and electronic element and electronic device using same SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-11-07 US disclosed
US-20230265063-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-08-24 US disclosed
US-20230265063-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-08-24 US disclosed
WO-2022267661-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME 陕西莱特光电材料股份有限公司 2022-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265063-A1 ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME PIEZO1, OR10J3, OR51E2 RXRA 2012/4885RARB 2354/4885RARG 2531/4885
US-11807616-B2 Organic compound, and electronic element and electronic device using same PIEZO1, OR10J3, OR51E2 RXRA 2012/4885RARB 2354/4885RARG 2531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.